Related Experiment Videos
Caspase 3 in breast cancer
Norma O'Donovan1, John Crown, Helen Stunell
1Department of Medical Oncology, St. Vincent's University Hospital, University College Dublin, Dublin 4, Ireland.
Summary
Apoptosis rates, measured by caspase 3 activation and nucleosome release, are higher in breast cancer than in normal tissue. This suggests the proliferation to apoptosis ratio may be elevated in carcinomas, challenging previous beliefs.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Apoptosis, or programmed cell death, is crucial in preventing uncontrolled cell growth.
- Caspase 3 is a key mediator of apoptosis.
- Dysregulation of apoptosis is implicated in cancer development and progression.
Purpose of the Study:
- To investigate caspase 3 mRNA and protein expression in breast cancer tissues.
- To assess apoptosis levels in breast cancer and compare them to non-malignant tissues.
Main Methods:
- Reverse transcription-polymerase chain reaction (RT-PCR) for caspase 3 mRNA.
- Western blotting and activity assays for caspase 3 protein.
- Enzyme-linked immunosorbent assay (ELISA) to quantify apoptosis via nucleosome release.
Main Results:
- Caspase 3 mRNA levels were similar across normal, fibroadenoma, and carcinoma tissues.
- Active caspase 3 protein levels and apoptosis rates were significantly higher in breast carcinomas compared to fibroadenomas and normal tissues.
- Higher apoptosis correlated with active caspase 3 levels in carcinomas, particularly in ductal types.
Conclusions:
- Apoptosis rates are elevated in breast cancer, contrary to the belief that it is reduced in malignancy.
- The proliferation to apoptosis ratio might be higher in carcinomas, contributing to tumor progression.